Pay in 4 interest-free payments of $6.31 Learn more
Ships within 48 hours · Estimated delivery Aug 19 - Aug 24
In these studies, AOD-9604 administered via intraperitoneal injection produced significant fat mass reduction without changes in food intake or lean body mass
the "PDA counterion argument" for regulatory compliance has not been validated by FDA guidance as of April 2026
laboratories with pharmaceutical-grade standards and over 99% purity
Published penetration studies using radiolabeled tracers have confirmed dermal absorption after topical application
US$ 26.91
US$ 27.29
US$ 20.10
US$ 20.24
US$ 29.71
US$ 27.12
US$ 20.02
US$ 22.51
US$ 24.04
